V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160017598 | 160016643 | 1.7 | 63.9 | Palliative (P) | 2019-02-22 | 2019-02-26 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | GEMCITABINE | 101167241 |
| 160017604 | 160016644 | 0 | 14.9 | null | 2018-06-30 | 2018-07-14 | Cisplatin + Paclitaxel | 02 | null | STS RHABDO VIT0910 VINC IRINOTECAN | 101663511 |
| 160017610 | 160016645 | 1.74 | 9.6 | Palliative (P) | 2019-01-16 | 2019-01-23 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | null | NIRAPARIB | 100706943 |
| 160000341 | 160016646 | 0 | 20 | Palliative (P) | 2019-10-17 | 2019-10-25 | null | 02 | N | METHOTREXATE | 100944148 |
| 160000825 | 160016647 | 1.68 | 73.6 | Palliative (P) | 2021-04-12 | 2021-04-22 | Abiraterone | 02 | N | CYCLOPHOSPHAMIDE + VINORELBINE | 100904085 |
| 160000895 | 160016648 | 1.67 | 85.4 | Palliative (P) | 2019-07-15 | 2019-08-07 | Niraparib | 01 | N | IVA | 100855895 |
| 160001486 | 160016649 | 1.67 | 21.8 | Neo-adjuvant (N) | 2020-01-03 | 2020-01-04 | null | Y | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101068815 |
| 160001867 | 160016650 | 1.68 | 65 | Curative (C) | 2018-08-14 | 2018-08-21 | CVP R | 02 | null | CYCLOPHOSPHAMIDE + VINORELBINE | 100608098 |
| 160002009 | 160016651 | 1 | null | Curative (C) | 2020-04-13 | 2020-04-27 | STS Rhabdo RMS 2005 Vin Cyclo | N | Y | IPILIMUMAB + NIVOLUMAB | 100169851 |
| 160002514 | 160016652 | 1.7 | 82.3 | null | 2017-04-13 | 2017-05-18 | NB Relapsed CCLG guidelines TVD | 02 | null | VINCRISTINE | 101490250 |
| 160002663 | 160016653 | 1.76 | 13.7 | Adjuvant (A) | 2020-01-22 | 2020-02-07 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | FLUOROURACIL + OXALIPLATIN | 100494391 |
| 160003333 | 160016654 | 0 | 74.1 | Palliative (P) | 2019-10-23 | 2020-02-10 | Dacarbazine | 01 | N | NOT MATCHED | 101395089 |
| 160003704 | 160016655 | 0.77 | 64 | Curative (C) | 2016-10-19 | 2016-10-19 | EW EuroEwing 2012 Arm B IE | N | N | GEMCITABINE | 101329324 |
| 160003966 | 160016656 | 0 | 78 | null | 2017-02-17 | 2018-03-08 | PROMISE-MESO TRIAL | 01 | null | EW EUROEWING 2012 ARM B IE | 100428369 |
| 160004368 | 160016658 | 1.1 | 78.5 | null | 2019-04-29 | 2019-11-14 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100394972 |
| 160005569 | 160016660 | 0 | 46.5 | Palliative (P) | 2020-08-10 | 2021-01-03 | ATOMIC-MESO TRIAL | N | N | STS RHABDO VIT0910 VINC IRINO TEMOZ | 100624484 |
| 160006388 | 160016661 | 1.62 | 91.8 | 02 | 2016-10-20 | 2016-10-20 | GEMCITABINE | 02 | N | TRIAL | 101297123 |
| 160006389 | 160016662 | null | 69.6 | Palliative (P) | 2020-03-06 | 2020-03-15 | EW EuroEwing 2012 Arm B VDC/IE | 02 | N | GEMCITABINE | 100953709 |
| 160006918 | 160016663 | null | null | null | 2019-10-29 | 2020-03-11 | CARBOPLATIN + VINORELBINE | 02 | null | DACTINOMYCIN + DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 100003836 |
| 160007240 | 160016664 | 1.64 | 73.4 | Palliative (P) | 2017-01-11 | 2017-04-10 | EW EuroEwing 2012 Arm A VAI | 02 | N | EW EUROEWING 2012 ARM B VC | 101524382 |
| 160007389 | 160016665 | 1.58 | 80 | Curative (C) | null | 2017-01-06 | STS Non-Rhabdo EpSSG 2005 IVA | 02 | N | DACTINOMYCIN + DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 100844374 |
| 160007904 | 160016666 | 1.6 | 69.35 | null | 2018-08-05 | 2018-08-15 | ICON8B TRIAL | 02 | null | GEMCITABINE | 100242429 |
| 160008433 | 160016667 | 1.46 | 19.4 | Palliative (P) | 2019-09-26 | 2019-10-11 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | NOT MATCHED | 100659790 |
| 160008630 | 160016668 | 1.6 | 65.9 | Curative (C) | 2022-01-12 | 2022-01-12 | Rucaparib | 02 | N | EW EUROEWING 2012 ARM A VAC | 100288187 |
| 160008800 | 160016669 | 1.63 | 57.4 | Curative (C) | 2017-09-11 | 2017-10-09 | Ifosfamide | 02 | N | NIRAPARIB | 100275941 |
| 160008830 | 160016670 | 1.54 | 105 | null | 2019-07-21 | 2020-04-11 | NB HRNBL-1 BUMEL MAT | 02 | null | OLARATUMAB | 100249825 |
| 160008933 | 160016671 | 1.56 | 77.3 | null | 2017-05-29 | 2017-06-10 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | null | ETOPOSIDE + IFOSFAMIDE | 101078869 |
| 160008964 | 160016672 | 1.77 | 77.6 | null | 2021-11-20 | 2021-12-05 | EW EuroEwing 2012 Arm B IE | null | null | GEMCITABINE | 101078776 |
| 160009384 | 160016674 | 1.64 | 75 | null | 2020-03-01 | 2020-03-01 | EW EuroEwing 2012 Arm B IE | 02 | null | NIRAPARIB | 101177507 |
| 160009476 | 160016676 | 1.56 | 94 | Palliative (P) | 2019-01-13 | 2019-01-27 | CONFIRM TRIAL | N | N | IVA | 100784347 |
| 160009659 | 160016677 | null | 77.6 | null | 2017-06-04 | 2017-06-05 | DACARBAZINE + DOXORUBICIN | N | null | TRIAL | 100847086 |
| 160009742 | 160016678 | 1.66 | 80.1 | null | null | 2018-02-23 | Ifosfamide | 02 | null | DOCETAXEL | 101683016 |
| 160009800 | 160016679 | 0 | 82.9 | Palliative (P) | 2016-05-21 | 2016-05-25 | Carboplatin + Vinorelbine Oral | 02 | N | GEMCITABINE | 100706611 |
| 160010151 | 160016681 | 1.67 | 66.1 | null | 2017-11-12 | 2018-08-12 | ETOP 13-18 BEAT-meso Trial | 02 | null | NB HRNBL | 100237670 |
| 160010269 | 160016683 | 0 | 64 | Curative (C) | 2019-07-04 | 2019-07-16 | CYCLOPHOSPHAMIDE | 02 | N | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 100684796 |
| 160010360 | 160016684 | 1.55 | 91.35 | Palliative (P) | 2018-03-16 | 2018-03-16 | CONFIRM TRIAL | 02 | N | CYCLOPHOSPHAMIDE + VINCRISTINE | 100726315 |
| 160010408 | 160016685 | 0.93 | 59 | null | 2017-07-31 | 2017-08-12 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | null | OLARATUMAB | 101861151 |
| 160010475 | 160016686 | 1.91 | 10.5 | Palliative (P) | 2018-08-21 | 2018-12-29 | Cisplatin + Etoposide po | 02 | N | GEMCITABINE + TREOSULFAN | 100519514 |
| 160010514 | 160016687 | null | null | Curative (C) | 2020-06-29 | 2020-07-08 | EW EuroEwing 2012 Arm A VIDE | 02 | N | ETOPOSIDE | 100292842 |
| 160010558 | 160016688 | 0 | 29.7 | Curative (C) | 2019-11-15 | 2020-02-15 | Cyclophosphamide oral | 02 | N | TRIAL | 100888364 |
| 160010801 | 160016690 | null | null | Palliative (P) | 2017-02-25 | 2017-05-14 | Dacarbazine | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100508709 |
| 160010902 | 160016692 | null | null | null | 2019-08-31 | 2019-10-29 | Trastuzumab 21 day maintenance | 02 | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 101515224 |
| 160010938 | 160016693 | 1.58 | 80 | null | 2018-10-23 | 2019-06-25 | null | 02 | null | GEMCITABINE | 101163903 |
| 160011166 | 160016694 | 0 | 16.4 | Palliative (P) | 2020-05-04 | 2020-05-23 | Olaparib | 02 | N | GEMCITABINE | 101542759 |
| 160011170 | 160016695 | 1.56 | 13.2 | null | 2020-02-10 | 2020-02-10 | LENALIDOMIDE | 02 | N | NB HRNBL-1 ISOTRETINOIN | 100199392 |
| 160011320 | 160016696 | 1.67 | 121.4 | Palliative (P) | 2017-11-06 | 2017-11-15 | EW EuroEwing 2012 Arm B IE | 02 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101746287 |
| 160011377 | 160016697 | 1.85 | 57.7 | null | 2020-08-13 | 2020-12-20 | EW Rel rEECur Irinotecan/Temozolomide | 02 | null | PEMBROLIZUMAB | 100726833 |
| 160011501 | 160016699 | 0 | 99.7 | null | 2019-03-04 | 2019-03-04 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | CARBOPLATIN + ETOPOSIDE | 100685188 |
| 160011782 | 160016700 | 1 | 74 | Curative (C) | 2018-01-08 | 2018-01-09 | null | 2 | N | ETOP 13-18 BEAT-MESO TRIAL | 101612656 |
| 160011895 | 160016701 | 1.64 | null | Palliative (P) | 2018-09-14 | 2019-04-13 | Rucaparib | 02 | N | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 101049355 |